Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


05.08.2019

1 Acta Neurol Scand
1 Brain
2 J Neurol
2 Lancet Neurol
11 Mult Scler
1 Neurology
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. FERRARO D, Guicciardi C, De Biasi S, Pinti M, et al
    Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients.
    Acta Neurol Scand. 2019 Jul 27. doi: 10.1111/ane.13152.
    PubMed     Text format     Abstract available


    Brain

  2. FEINSTEIN A, Meza C, Stefan C, Staines RW, et al
    Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
    Brain. 2019 Jul 30. pii: 5541023. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Neurol

  3. RASTAS C, Sirignano D, Barner A, Bruno-Murtha LA, et al
    Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis.
    J Neurol. 2019 Jul 26. pii: 10.1007/s00415-019-09483.
    PubMed     Text format    

  4. INOJOSA H, Proschmann U, Akgun K, Ziemssen T, et al
    A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition.
    J Neurol. 2019 Jul 30. pii: 10.1007/s00415-019-09489.
    PubMed     Text format     Abstract available


    Lancet Neurol

  5. GIOVANNONI G
    Do we have equipoise when it comes to how we treat active multiple sclerosis?
    Lancet Neurol. 2019 Jul 30. pii: S1474-4422(19)30227.
    PubMed     Text format    

  6. ONTANEDA D, Tallantyre E, Kalincik T, Planchon SM, et al
    Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis.
    Lancet Neurol. 2019 Jul 30. pii: S1474-4422(19)30151.
    PubMed     Text format     Abstract available


    Mult Scler

  7. BOESEN F, Norgaard M, Trenel P, Rasmussen PV, et al
    Longer term effectiveness of inpatient multidisciplinary rehabilitation on health-related quality of life in MS patients: a pragmatic randomized controlled trial - The Danish MS Hospitals Rehabilitation Study.
    Mult Scler. 2017 Oct 1:1352458517735188. doi: 10.1177/1352458517735188.
    PubMed     Text format     Abstract available

  8. PRAVATA E, Valsasina P, Gobbi C, Zecca C, et al
    Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis.
    Mult Scler. 2019 Jul 26:1352458519865989. doi: 10.1177/1352458519865989.
    PubMed     Text format     Abstract available

  9. LARSSON D, Akerfeldt T, Carlson K, Burman J, et al
    Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis.
    Mult Scler. 2019 Jul 26:1352458519863983. doi: 10.1177/1352458519863983.
    PubMed     Text format     Abstract available

  10. CAMPBELL JA, Simpson S Jr, Ahmad H, Taylor BV, et al
    Change in multiple sclerosis prevalence over time in Australia 2010-2017 utilising disease-modifying therapy prescription data.
    Mult Scler. 2019 Jul 26:1352458519861270. doi: 10.1177/1352458519861270.
    PubMed     Text format     Abstract available

  11. SCHWEHR NA, Kuntz KM, Butler M, Enns EA, et al
    Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis.
    Mult Scler. 2019 Jul 29:1352458519866613. doi: 10.1177/1352458519866613.
    PubMed     Text format     Abstract available

  12. SOTIRCHOS ES, Filippatou A, Fitzgerald KC, Salama S, et al
    Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.
    Mult Scler. 2019 Jul 31:1352458519864928. doi: 10.1177/1352458519864928.
    PubMed     Text format     Abstract available

  13. BEECHAM AH, Amezcua L, Chinea A, Manrique CP, et al
    The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.
    Mult Scler. 2019 Aug 1:1352458519863764. doi: 10.1177/1352458519863764.
    PubMed     Text format     Abstract available

  14. BOVE R, Rankin K, Lin C, Zhao C, et al
    Effect of assisted reproductive technology on multiple sclerosis relapses: Case series and meta-analysis.
    Mult Scler. 2019 Aug 1:1352458519865118. doi: 10.1177/1352458519865118.
    PubMed     Text format     Abstract available

  15. MCGINLEY MP, Cola PA, Fox RJ, Cohen JA, et al
    Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies.
    Mult Scler. 2019 Aug 1:1352458519867314. doi: 10.1177/1352458519867314.
    PubMed     Text format     Abstract available

  16. HERRANZ E, Louapre C, Treaba CA, Govindarajan ST, et al
    Profiles of cortical inflammation in multiple sclerosis by (11)C-PBR28 MR-PET and 7 Tesla imaging.
    Mult Scler. 2019 Aug 1:1352458519867320. doi: 10.1177/1352458519867320.
    PubMed     Text format     Abstract available

  17. SIVAKOLUNDU DK, West KL, Maruthy GB, Zuppichini M, et al
    Reduced arterial compliance along the cerebrovascular tree predicts cognitive slowing in multiple sclerosis: Evidence for a neurovascular uncoupling hypothesis.
    Mult Scler. 2019 Aug 2:1352458519866605. doi: 10.1177/1352458519866605.
    PubMed     Text format     Abstract available


    Neurology

  18. HAPFELMEIER A, Gasperi C, Donnachie E, Hemmer B, et al
    A large case-control study on vaccination as risk factor for multiple sclerosis.
    Neurology. 2019 Jul 30. pii: WNL.0000000000008012.
    PubMed     Text format     Abstract available


    PLoS One

  19. EHLING R, Bsteh G, Muehlbacher A, Hermann K, et al
    Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis.
    PLoS One. 2019;14:e0220613.
    PubMed     Text format     Abstract available

  20. GRIMALDI AE, De Giglio L, Haggiag S, Bianco A, et al
    The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
    PLoS One. 2019;14:e0219670.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  21. TENGVALL K, Huang J, Hellstrom C, Kammer P, et al
    Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
    Proc Natl Acad Sci U S A. 2019 Aug 2. pii: 1902623116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: